Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Breast Cancer

• Publication date

  2016-05-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clbc.2016.07.014PMID 27553811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survival of a cohort of 25 breast cancer patients with neoplastic meningitis treated with intrathecal liposomal cytarabine.

  2016cited by this paper
• Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis.

  2016cited by this paper
• A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis

  2015cited by this paper
• Abstract P5-19-17: Final results of the phase I "HIT" study: A multicenter phase I-II study evaluating trastuzumab administered by intrathecal injection for leptomeningeal meningitis of HER2+ metastatic breast cancer (MBC)

  2015cited by this paper
• Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.

  2015cited by this paper
• Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.

  2015cited by this paper
• Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial

  2015cited by this paper
• Central Nervous System Cancers, Version 1.2015.

  2015cited by this paper
• Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases

  2015cited by this paper
• Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.

  2014cited by this paper
• Leptomeningeal disease and breast cancer: the importance of tumor subtype

  2014cited by this paper
• Phase II trial of patupilone in patients with brain metastases from breast cancer.

  2014cited by this paper
• Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study

  2014cited by this paper
• Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis

  2013cited by this paper
• Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases

  2013cited by this paper
• Prolonged Regression of Metastatic Leptomeningeal Breast Cancer That Has Failed Conventional Therapy: A Case Report and Review of the Literature

  2013cited by this paper
• Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival

  2013cited by this paper
• Response of Meningeal Carcinomatosis from Breast Cancer to Capecitabine Monotherapy: A Case Report

  2013cited by this paper
• Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa

  2013cited by this paper
• Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience

  2013cited by this paper
• Neoplastic Meningitis from Solid Tumors: A Prospective Clinical Study in Lombardia and a Literature Review on Therapeutic Approaches

  2013cited by this paper
• Leptomeningeal metastases in breast cancer.

  2013cited by this paper
• Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients

  2013cited by this paper
• Carcinomatous meningitis: Leptomeningeal metastases in solid tumors

  2013cited by this paper
• Prospective follow-up of a cohort of 112 patients with leptomeningeal metastases of breast cancer recruited from 2007 to 2011: Prognostic factors.

  2012cited by this paper
• Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors

  2012cited by this paper
• Validation of the Institut Curie simplified prognostic score for breast cancer meningeal carcinomatosis.

  2011cited by this paper
• Clinicopathological features of breast cancers predict the development of leptomeningeal metastases: a case-control study

  2011cited by this paper
• Meningeal carcinomatosis in breast cancer: prognostic factors and outcome

  2011cited by this paper
• The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

  2011cited by this paper
• Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study.

  2011cited by this paper
• 5059 POSTER Systemic High-dose Intravenous Methotrexate for Central Nervous System Metastases in Breast Cancer

  2011cited by this paper
• Survival of breast cancer patients with meningeal carcinomatosis.

  2010cited by this paper
• Leptomeningeal metastases in the MRI era

  2010cited by this paper
• Pathological characteristics and prognosis of a cohort of 74 patients (pts) with breast cancer (BC) with neoplastic meningitis (NM).

  2010cited by this paper
• 479 Primary breast cancer phenotype associated with propensity for leptomeningeal metastases

  2010cited by this paper
• Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis

  2010cited by this paper
• Leptomeningeal metastasis

  2010cited by this paper
• Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.

  2008cited by this paper
• Contrast-Enhancing Meningeal Lesions Are Associated with Longer Survival in Breast Cancer-Related Leptomeningeal Metastasis

  2008cited by this paper
• Leptomeningeal metastasis in solid tumours: Is there a role for intrathecal therapy?

  2007cited by this paper
• Capecitabine Therapy of Central Nervous System Metastases from Breast Cancer

  2007cited by this paper
• Breast cancer leptomeningeal metastasis—the role of multimodality treatment

  2007cited by this paper
• Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report.

  2006cited by this paper
• A randomized phase III/IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitis.

  2006cited by this paper
• Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse.

  2006cited by this paper
• Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis

  2006cited by this paper
• Systemic high-dose intravenous methotrexate for central nervous system metastases

  2006cited by this paper
• Neoplastic Meningitis

  2006cited by this paper
• Intrathecal chemotherapy for patients with meningeal carcinomatosis.

  2005cited by this paper
• The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.

  2004cited by this paper
• The treatment of neoplastic meningitis

  2004cited by this paper
• Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.

  2004cited by this paper
• An Open Label Trial of Sustained-release Cytarabine (DepoCyt™) for the Intrathecal Treatment of Solid Tumor Neoplastic Meningitis

  2004cited by this paper
• Clinical Trial of Intrathecal Administration of 5-fluoro-2′-deoxyuridine for Treatment of Meningeal Dissemination of Malignant Tumors

  2004cited by this paper
• Response of Neoplastic Meningitis from Solid Tumors to Oral Capecitabine

  2003cited by this paper
• Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.

  2002cited by this paper
• A Phase II trial of intra‐cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis

  2002cited by this paper
• Neoplastic meningitis

  2002cited by this paper
• The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy.

  2001cited by this paper
• A United Kingdom coordinating committee on cancer research study of adjuvant chemotherapy for colorectal cancer: preliminary results.

  2001cited by this paper
• Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

  2001cited by this paper
• Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer

  2000cited by this paper
• A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

  1999cited by this paper
• Leptomeningeal carcinomatosis.

  1999cited by this paper
• High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

  1998cited by this paper
• Leptomeningeal metastases from solid tumors

  1998cited by this paper
• Meningeal carcinomatosis in patients with breast carcinoma: Clinical features, prognostic factors, and results of a high‐dose intrathecal methotrexate regimen

  1996cited by this paper
• Blood-brain interfaces: relevance to cerebral drug metabolism.

  1995cited by this paper
• Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

  1993cited by this paper
• Whole brain irradiation and intrathecal Methotrexate in the treatment of solid tumor leptomeningeal metastases — A Southwest Oncology Group study

  1988cited by this paper
• A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.

  1987cited by this paper
• Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis

  1987cited by this paper
• Combination intraventricular chemotherapy for meningeal neoplasia.

  1986cited by this paper
• Estrogen and progesterone receptors in prediction of metastatic behavior of breast carcinoma.

  1984cited by this paper
• Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients

  1982cited by this paper
• Alteration of blood-CSF barrier by tumor invasion into the meninges.

  1981cited by this paper
• Meningeal carcinomatosis in breast cancer presenting as central hypoventilation: A case report with a brief review of the literature

  1981cited by this paper
• Leptomeningeal spread of breast cancer: Report of case and review of the literature

  1981cited by this paper
• Blindness as initial manifestation of meningeal carcinomatosis in breast cancer

  1979cited by this paper
• Meningeal carcinomatosis

  1976cited by this paper

• Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study

  2025cites this paper
• Efficacy of trastuzumab deruxtecan in treating HER2-low breast cancer leptomeningeal metastasis: a case report.

  2024cites this paper
• DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer

  2024influential citation
• Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature

  2024cites this paper
• An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?

  2023cites this paper
• [Spinal metastases combined with leptomeningeal metastasis: A case report].

  2023cites this paper
• Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers

  2023cites this paper
• Treatment of breast cancer brain metastases: radiotherapy and emerging preclinical approaches

  2022cites this paper
• Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program

  2022cites this paper
• Long survival of a patient with leptomeningeal infiltration in breast cancer: A case report

  2022cites this paper
• Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis

  2021cites this paper
• Leptomeningeal Carcinomatosis Secondary to Adenocarcinoma of the Breast: A Cadaveric Case Report

  2021cites this paper
• ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer

  2021cites this paper
• Local and systemic therapy in breast cancer patients with central nervous system metastases

  2021cites this paper
• Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review

  2020cites this paper
• Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies

  2020cites this paper
• A rare magnetic resonance imaging pattern of leptomeningeal carcinomatosis: a case description.

  2020cites this paper
• Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases

  2019cites this paper
• Leptomeningeal carcinomatosis following neoplastic cerebral aneurysm rupture: a case report.

  2019cites this paper
• Leptomeningeal carcinomatosis in patients with breast cancer.

  2019cites this paper
• Breast leptomeningeal disease: a review of current practices and updates on management

  2019cites this paper
• Natural Language Processing to Assess Palliative Care and End-of-Life Process Measures in Patients With Breast Cancer With Leptomeningeal Disease

  2019cites this paper
• F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

  2018cites this paper
• Palliative Radiation Therapy for Leptomeningeal Disease

  2018cites this paper
• Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.

  2018influential citation
• Guidelines for diagnosis , treatment and follow-up of patients with leptomeningeal metastasis from solid tumours †

  2017cites this paper
• Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.

  2017cites this paper
• Current challenges in the management of breast cancer brain metastases.

  2017cites this paper
• EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.

  2017cites this paper
• Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part I.

  2016cites this paper